DEVELOPMENT OF NANOCARRIER FOR ANTICANCER BASED ON POTENCY OF P-gp EFFLUX INHIBITION SCREENING
Multi Drug Resistance (MDR) is a problem in cancer therapy. The main cause of resistance is the over expression of P-glycoprotein (P-gp) and its activity to cause efflux of anticancer drugs. To overcome this problem, it is necessary to use MDR inhibitors to suppress P-gp activity so that anticanc...
Saved in:
Main Author: | Agus Syamsur Rijal, Muh |
---|---|
Format: | Dissertations |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/34181 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
SECONDARY METABOLITES FROM INDONESIAN CRYPTOCARYA AND THEIR POTENCY AS ANTICANCER
by: Nabila Farahnita, Shaffa -
The Potential of Camellia sinensis Extract to Prevent HIV/AIDS Transmission Risk Through the Inhibition of Syncytium, GP120, and GP41 Formation
by: Retno Pudji Rahayu, et al.
Published: (2019) -
SECONDARY METABOLITES ISOLATION OF CRYPTOCARYA AND IN SILICO STUDY OF ITS ANTICANCER POTENCY
by: Citra Violeta, Tasya -
Development and characterization of a nanocarrier for quercetin
by: Wong, M.-Y., et al.
Published: (2014) -
Inhibition of the norA gene expression and the NorA efflux pump by the tannic acid
by: Tintino S.R.
Published: (2023)